Investing in new medical technologies: A decision framework
- 1 August 2007
- journal article
- Published by thinkBiotech, LLC in Journal of Commercial Biotechnology
- Vol. 13 (4), 263-271
- https://doi.org/10.1057/palgrave.jcb.3050062
Abstract
Journal of Commercial Biotechnology is a peer-reviewed journal on the business of biotechnology which focuses on the commercial, legal, and regulatory issues affecting biotech companiesKeywords
This publication has 16 references indexed in Scilit:
- The economic consequences of prostate and bladder cancer in the UKBJU International, 2004
- Buccal mucosal urethroplasty: is it the new gold standard?BJU International, 2004
- Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general publicQuality of Life Research, 2003
- Problems and solutions in calculating quality-adjusted life years (QALYs)Health and Quality of Life Outcomes, 2003
- The Health Utilities Index (HUI®): concepts, measurement properties and applicationsHealth and Quality of Life Outcomes, 2003
- Tissue engineering firms go underNature Biotechnology, 2002
- Valuing health states: A comparison of methodsJournal of Health Economics, 1996
- Clinical outcome and quality of life following enterocystoplasty for idiopathic detrusor instability and neurogenic bladder dysfunctionBritish Journal of Urology, 1995
- The Short-Form 36 (SF-36) Health Survey and Its Use in Pharmacoeconomic EvaluationPharmacoEconomics, 1995
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990